Dr. Samer Salka Md
15120 Michigan Ave Suite A
Dearborn MI 48126
313 248-8417
Medical School: Other - 1985
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: No
Participates In EHR: Yes
License #: SS051535
NPI: 1811956139
Taxonomy Codes:
207RC0000X
Request Appointment Information
Awards & Recognitions
About Us
Practice Philosophy
Conditions
Dr. Samer Salka is associated with these group practices
Procedure Pricing
| HCPCS Code | Description | Average Price | Average Price Allowed By Medicare |
|---|---|---|---|
| HCPCS Code:92980 | Description:Insert intracoronary stent | Average Price:$1,485.00 | Average Price Allowed By Medicare:$919.07 |
| HCPCS Code:93458 | Description:L hrt artery/ventricle angio | Average Price:$620.00 | Average Price Allowed By Medicare:$295.74 |
| HCPCS Code:93320 | Description:Doppler echo exam heart | Average Price:$300.00 | Average Price Allowed By Medicare:$55.89 |
| HCPCS Code:93880 | Description:Extracranial study | Average Price:$430.00 | Average Price Allowed By Medicare:$187.27 |
| HCPCS Code:93268 | Description:ECG record/review | Average Price:$480.00 | Average Price Allowed By Medicare:$244.53 |
| HCPCS Code:93351 | Description:Stress tte complete | Average Price:$470.00 | Average Price Allowed By Medicare:$250.36 |
| HCPCS Code:93306 | Description:Tte w/doppler complete | Average Price:$425.00 | Average Price Allowed By Medicare:$219.28 |
| HCPCS Code:78452 | Description:Ht muscle image spect mult | Average Price:$690.00 | Average Price Allowed By Medicare:$517.36 |
| HCPCS Code:93923 | Description:Upr/lxtr art stdy 3+ lvls | Average Price:$330.00 | Average Price Allowed By Medicare:$166.38 |
| HCPCS Code:93224 | Description:Ecg monit/reprt up to 48 hrs | Average Price:$250.00 | Average Price Allowed By Medicare:$102.12 |
| HCPCS Code:93015 | Description:Cardiovascular stress test | Average Price:$200.00 | Average Price Allowed By Medicare:$91.32 |
| HCPCS Code:93922 | Description:Upr/l xtremity art 2 levels | Average Price:$215.00 | Average Price Allowed By Medicare:$107.08 |
| HCPCS Code:99220 | Description:Initial observation care | Average Price:$285.00 | Average Price Allowed By Medicare:$188.45 |
| HCPCS Code:99205 | Description:Office/outpatient visit new | Average Price:$295.00 | Average Price Allowed By Medicare:$211.21 |
| HCPCS Code:99223 | Description:Initial hospital care | Average Price:$290.00 | Average Price Allowed By Medicare:$207.55 |
| HCPCS Code:99407 | Description:Behav chng smoking > 10 min | Average Price:$100.00 | Average Price Allowed By Medicare:$27.95 |
| HCPCS Code:93325 | Description:Doppler color flow add-on | Average Price:$100.00 | Average Price Allowed By Medicare:$29.44 |
| HCPCS Code:99406 | Description:Behav chng smoking 3-10 min | Average Price:$80.00 | Average Price Allowed By Medicare:$14.19 |
| HCPCS Code:99215 | Description:Office/outpatient visit est | Average Price:$205.00 | Average Price Allowed By Medicare:$146.81 |
| HCPCS Code:99204 | Description:Office/outpatient visit new | Average Price:$225.00 | Average Price Allowed By Medicare:$170.46 |
| HCPCS Code:93280 | Description:Pm device progr eval dual | Average Price:$115.00 | Average Price Allowed By Medicare:$61.64 |
| HCPCS Code:99233 | Description:Subsequent hospital care | Average Price:$155.00 | Average Price Allowed By Medicare:$105.53 |
| HCPCS Code:99232 | Description:Subsequent hospital care | Average Price:$110.00 | Average Price Allowed By Medicare:$73.49 |
| HCPCS Code:93288 | Description:Pm device eval in person | Average Price:$75.00 | Average Price Allowed By Medicare:$39.16 |
| HCPCS Code:99231 | Description:Subsequent hospital care | Average Price:$75.00 | Average Price Allowed By Medicare:$40.32 |
| HCPCS Code:99214 | Description:Office/outpatient visit est | Average Price:$140.00 | Average Price Allowed By Medicare:$109.19 |
| HCPCS Code:93000 | Description:Electrocardiogram complete | Average Price:$45.00 | Average Price Allowed By Medicare:$20.03 |
| HCPCS Code:99213 | Description:Office/outpatient visit est | Average Price:$95.00 | Average Price Allowed By Medicare:$73.93 |
| HCPCS Code:99212 | Description:Office/outpatient visit est | Average Price:$65.00 | Average Price Allowed By Medicare:$44.59 |
| HCPCS Code:Q2036 | Description:Flulaval vacc, 3 yrs & >, im | Average Price:$26.00 | Average Price Allowed By Medicare:$9.83 |
| HCPCS Code:99211 | Description:Office/outpatient visit est | Average Price:$35.00 | Average Price Allowed By Medicare:$20.46 |
| HCPCS Code:J0280 | Description:Aminophyllin 250 MG inj | Average Price:$10.00 | Average Price Allowed By Medicare:$0.42 |
| HCPCS Code:J2785 | Description:Regadenoson injection | Average Price:$62.50 | Average Price Allowed By Medicare:$52.94 |
| HCPCS Code:85610 | Description:Prothrombin time | Average Price:$15.00 | Average Price Allowed By Medicare:$5.56 |
| HCPCS Code:G0008 | Description:Admin influenza virus vac | Average Price:$30.00 | Average Price Allowed By Medicare:$24.99 |
| HCPCS Code:A9500 | Description:Tc99m sestamibi | Average Price:$200.00 | Average Price Allowed By Medicare:$200.00 |
HCPCS Code Definitions
- 93351
- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional
- 78452
- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection
- 93000
- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
- 93325
- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)
- 93224
- External electrocardiographic recording up to 48 hours by continuous rhythm recording and storage; includes recording, scanning analysis with report, review and interpretation by a physician or other qualified health care professional
- 93320
- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete
- 93015
- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; with supervision, interpretation and report
- 93306
- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography
- 93288
- Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system
- 93280
- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system
- 99205
- Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.
- 93458
- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed
- 99204
- Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
- 99406
- Smoking and tobacco use cessation counseling visit; intermediate, greater than 3 minutes up to 10 minutes
- 99211
- Office or other outpatient visit for the evaluation and management of an established patient, that may not require the presence of a physician or other qualified health care professional. Usually, the presenting problem(s) are minimal. Typically, 5 minutes are spent performing or supervising these services.
- 93923
- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia)
- 93922
- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels)
- 93880
- Duplex scan of extracranial arteries; complete bilateral study
- 99233
- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
- 99220
- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission to "observation status" are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
- 99215
- Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.
- 99214
- Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
- 99213
- Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
- 99212
- Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
- 99232
- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
- 93268
- External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; includes transmission, review and interpretation by a physician or other qualified health care professional
- 99231
- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is stable, recovering or improving. Typically, 15 minutes are spent at the bedside and on the patient's hospital floor or unit.
- 99223
- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
- Q2036
- Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
- A9500
- Technetium tc-99m sestamibi, diagnostic, per study dose
- 99407
- Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes
- J2785
- Injection, regadenoson, 0.1 mg
- J0280
- Injection, aminophyllin, up to 250 mg
- G0008
- Administration of influenza virus vaccine
Medical Malpractice Cases
None Found
Medical Board Sanctions
None Found
Referrals
NPI
Doctor Name
Specialty
Count
*These referrals represent the top 10 that Dr. Salka has made to other doctors
Publications
Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than Medicare payments. - Clinical cardiology
Acute coronary syndromes account for half of all deaths secondary to cardiovascular disease and represent a significant economic burden in the United States. Therefore, assessing hospitalization costs relative to Medicare reimbursement for these patients is important in understanding the impact of these patients on hospitals. We hypothesized that hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention (PCI) were higher than their associated Medicare payments.Using the Nationwide Inpatient Sample, we evaluated hospitalization costs for patients treated with PCI from 2001 through 2009 by multiplying hospital charges by the group average cost-to-charge ratio for each patient's hospitalization. Primary end points examined were total hospital costs and trends over time, which were correlated with clinical outcomes and insurance payments. Costs were inflation adjusted with 2009 as the reference year.Median hospitalization costs of PCI increased from $15 889 (interquartile range [IQR] = $12 057-$21 204) in 2001 to $19 349 (IQR = $14 660-$26 282) in 2009. From 2004 to 2009, inflation-adjusted costs for PCI decreased at a rate of 0.3% per year. In 2009, a total of 265,531 patients received PCI for acute myocardial infarction. Of these, 143 654 were <65 years old, and 121 876 were ≥65 years old. Average 2009 Medicare payments ranged from $9303 to $17 500 depending on the Medicare Severity-Diagnosis Related Groups (MS-DRG) billed, leaving hospitals at a loss of anywhere from $4493 to $7940 per patient when comparing costs and reimbursements across all included MS-DRG codes.Hospitalization costs for patients treated with PCI have been stabilizing over the last few years; however, there still remains a significant disparity between Medicare reimbursements and hospitalization costs, which has potential implications on patient outcomes, quality of care, and hospital sustainability.© 2014 Wiley Periodicals, Inc.
In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. - American heart journal
Takotsubo cardiomyopathy is characterized by acute, reversible left ventricular apical ballooning. Little is known about the characteristics of patients with takotsubo cardiomyopathy who have in-hospital mortality. We sought to determine in-hospital mortality rate, complication rate, and characteristics of patients with in-hospital mortality related to takotsubo cardiomyopathy.Patients diagnosed with takotsubo cardiomyopathy in the National Inpatient Database Samples 2008 to 2009 using International Classification of Diseases, Ninth Revision, code 42983 were included in this study. Our primary outcome was in-hospital mortality. In patients with takotsubo cardiomyopathy, we assessed demographic factors, the prevalence and associated mortality of underlying critical illnesses (acute ischemic stroke, sepsis, acute renal failure, respiratory insufficiency, and noncardiac surgery), and acute complications (acute congestive heart failure, respiratory insufficiency with congestive heart failure, cardiogenic shock, ventricular fibrillation/cardiac arrest, and intraaortic balloon pump placement).A total of 24,701 patients with takotsubo cardiomyopathy were identified. In-hospital mortality rate was 4.2%. A total of 21,994 patients (89.0%) were female. Male patients had a higher mortality rate than females (8.4% vs 3.6%, P < .0001). Age and race were not associated with mortality. Of patients with in-hospital mortality, 81.4% had underlying critical illnesses. Male patients with takotsubo had higher incidence of underlying critical illnesses than their female counterparts (36.6% vs 26.8%, P < .0001).The presence of underlying critical illness was the main driver of mortality, as these patients comprised >80% of patients with in-hospital mortality. Male patients, who were significantly more likely to have underlying critical illness, had significantly higher mortality rates than female patients. The presence of underlying critical illness likely explains the higher mortality rate among male patients.Copyright © 2012 Mosby, Inc. All rights reserved.
Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy. - The American journal of cardiology
Little is known about the epidemiology of stress (takotsubo) cardiomyopathy (SC). We used a 3-arm case-control study to assess differences in demographic and co-morbid predictors of SC compared to orthopedic controls and myocardial infarction (MI) controls to characterize (1) population-level predictors of SC generally and (2) differences and similarities in determinants of SC compared to MI. We included data on all discharges of patients diagnosed with SC from the 2008 to 2009 National Inpatient Samples and randomly selected 1-to-1 age-matched controls from patients hospitalized with MI and patients hospitalized with joint injuries after trauma. We used McNemar tests to assess differences in demographic characteristics and co-morbidities between patients with SC and controls. There were 24,701 patients with SC in our study. Of patients with SC, 89.0% were women compared to 38.9% of patients with MI and 55.7% of orthopedic controls. Patients with SC were more likely to be white and to reside in wealthier ZIP codes compared to MI and orthopedic controls. Patients with SC were less likely to have cardiovascular risk factors compared to MI and orthopedic controls but were more likely to have had histories of cerebrovascular accidents, drug abuse, anxiety disorders, mood disorders, malignancy, chronic liver disease, and sepsis. In conclusion, demographic and co-morbid predictors of SC differ substantially from those of MI and may be of interest to providers when diagnosing SC. Several co-morbid risk factors predictive of SC may operate by increased catecholamines.Copyright © 2012 Elsevier Inc. All rights reserved.
Proximal right coronary artery diverticulum resulting in recurrent distal embolization. - The Journal of invasive cardiology
This is a case of a right coronary artery (RCA) diverticulum. We highlight the complications of distal embolization and recurrent myocardial infarctions (MI), and the successful closure with a covered stent. A 33-year-old Khat user experienced non-ST elevation MI (non-STEMI) 3 times over 2 years. His first cardiac catheterization showed a proximal RCA ulceration. The last catheterization revealed a proximal RCA diverticulum containing a thrombus, and a thrombus at the distal PDA. A covered Jomed® stent (Jomed International AB) was placed into the proximal RCA, closing the diverticulum, and preventing future embolizations. Patient's atherosclerotic ulceration led to diverticular disease that resulted in blood flow stasis, thrombi, distal embolization, and repeat acute coronary events.
Electrophysiologic Studies in Octogenarians. - The American journal of geriatric cardiology
To assess the risk-benefit of electrophysiologic studies (EPS) in very elderly patients, we studied 104 consecutive patients 80 years or older who underwent EPS during hospitalization. Seventy-two percent of the patients had a history of coronary artery disease, and 7% had an acute myocardial infarction during the hospitalization. Other cardiac disorders included valvular heart disease (17%) and cardiomyopathy (12%). Abnormal systolic left ventricular function was common, with a left ventricular ejection fraction of 30% or less in 25% of the patients. The most common indication for EPS was unexplained syncope or presyncope (62 patients). Other indications for EPS included evaluation of cardiac arrest (9 patients), sustained monomorphic ventricular tachycardia (7), nonsustained ventricular tachycardia (22), wide QRS tachycardia (1), symptomatic sinus bradycardia (2) and palpitations (1). Thirty-eight patients (37%) demonstrated EPS findings considered to be responsible for the patients' symptoms. Specific clinical characteristics of the patients were not predictive of abnormal EPS findings. After EPS, 60% of the patients had a change in therapy; more than 75% of the patients who presented with sustained ventricular tachycardia or who had survived cardiac arrest and 58% of patients who presented with syncope had a change in therapy after EPS. Complications secondary to EPS occurred in only 3 patients; mortality or neurological complications were not associated with the procedure. We conclude that EPS can be performed safely in very elderly patients and that the procedure is beneficial in that therapy is modified on the basis of the EPS findings.
Nearby Doctors
